# CAFCIT

NDC: 0641-6164
Generic name: caffeine citrate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20081104
Marketing ended: 20260601
FDA application: NDA020793

## Active ingredients

- CAFFEINE CITRATE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6164"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6164
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9feb925-e1b8-41bc-b9c5-89198f07c0e9